KIAA1797 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.216000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.341000E-01
Normal-vs-Stage2
4.079400E-01
Normal-vs-Stage3
3.609800E-01
Normal-vs-Stage4
6.478400E-01
Stage1-vs-Stage2
1.939770E-02
Stage1-vs-Stage3
1.599210E-01
Stage1-vs-Stage4
3.291800E-01
Stage2-vs-Stage3
4.319800E-01
Stage2-vs-Stage4
8.261600E-01
Stage3-vs-Stage4
4.802400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.384400E-01
Normal-vs-AfricanAmerican
9.821400E-01
Normal-vs-Asian
1.354960E-01
Caucasian-vs-AfricanAmerican
5.278800E-01
Caucasian-vs-Asian
1.562020E-01
AfricanAmerican-vs-Asian
5.161600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.883600E-01
Normal-vs-Female
7.526800E-01
Male-vs-Female
3.691400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.247800E-01
Normal-vs-Age(41-60Yrs)
4.890200E-01
Normal-vs-Age(61-80Yrs)
7.251800E-01
Normal-vs-Age(81-100Yrs)
2.475000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.736000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.798800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.003400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.263800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.063200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.501160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.308600E-01
Normal-vs-Daily Drinker
3.270400E-01
Normal-vs-Weekly Drinker
4.658400E-01
Normal-vs-Occasional Drinker
9.398400E-01
Normal-vs-Social Drinker
9.457400E-01
Non Drinker-vs-Daily Drinker
8.450000E-01
Non Drinker-vs-Weekly Drinker
3.386400E-01
Non Drinker-vs-Occasional Drinker
1.971780E-01
Non Drinker-vs-Social Drinker
2.758100E-02
Daily Drinker-vs-Weekly Drinker
4.926800E-01
Daily Drinker-vs-Occasional Drinker
2.370800E-01
Daily Drinker-vs-Social Drinker
7.018400E-02
Weekly Drinker-vs-Occasional Drinker
4.022600E-01
Weekly Drinker-vs-Social Drinker
2.388400E-01
Occasional Drinker-vs-Social Drinker
9.299200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.412000E-01
Normal-vs-Grade 2
9.819200E-01
Normal-vs-Grade 3
7.664000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.163200E-01
Grade 1-vs-Grade 3
9.245800E-01
Grade 1-vs-Grade 4
8.412000E-01
Grade 2-vs-Grade 3
2.676000E-01
Grade 2-vs-Grade 4
9.819200E-01
Grade 3-vs-Grade 4
7.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.249200E-01
Normal-vs-NonDiabetic
6.839000E-01
Diabetic-vs-NonDiabetic
3.135600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.224600E-01
Normal-vs-NoPancreatitis
6.337800E-01
Pancreatitis-vs-NoPancreatitis
8.107400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.440600E-01
Normal-vs-N1
4.029400E-01
N0-vs-N1
1.469580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.141200E-01
Normal-vs-TP53-NonMutant
8.996800E-01
TP53-Mutant-vs-TP53-NonMutant
2.160300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
